Get started
Author

Christoph Schaefers

Carcinoembryonic antigen‐related cell adhesion molecule 1 controls IL‐2‐dependent regulatory T‐cell induction in immune‐mediated hepatitis in mice
2018 · Andrea Kristina Horst, Claudia Wegscheid, et al. · Hepatology · 30
Immune Thrombocytopenic Purpura after vaccination with COVID-19 Vaccine (ChAdOx1 nCov-19)
2021 · Finn-Ole Paulsen, Christoph Schaefers, et al. · Blood · 29
PDF
The prognostic impact of the smoking status of cancer patients receiving systemic treatment, radiation therapy, and surgery: A systematic review and meta-analysis
2022 · Christoph Schaefers, Christoph Seidel, et al. · European Journal of Cancer · 23
Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement
2025 · Maximilian J. Steinhardt, Christoph Schaefers, et al. · Blood Cancer Journal · 16
PDF
Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysis
2024 · C. Seidel, C. Schaefers, et al. · ESMO Open · 15
PDF
Increased incidence of immune thrombocytopenia ( ITP ) in 2021 correlating with the ongoing vaccination campaign against COVID ‐19 in a tertiary center – A monocentric analysis
2023 · C. Schaefers, F.‐O. Paulsen, et al. · British Journal of Haematology · 6
PDF
Extramedullary plasmacytoma in children is a genetically distinct localized neoplasia curable by surgical resection
2025 · Ilske Oschlies, Julia Richter, et al. · Blood Advances · 5
PDF
BCMA x CD3 T-cell engager in a patient with pentarefractory multiple myeloma and HIV: a clinical and immunological report
2024 · Leon Cords, Christoph Schaefers, et al. · Haematologica · 3
PDF
Supportive care for talquetamab-related dysgeusia in multiple myeloma: mixed-methods evidence, nutrition-focused flowchart, and digital companion concept
2026 · Anna Fleischer, Magdalena Roll, et al. · Supportive Care in Cancer · 2
Navigating the Post‐ BCMA / GPRC5D Landscape: Efficacy of Selinexor, Bortezomib, and Dexamethasone After Sequential Immunotherapy Failure in Penta‐Refractory Multiple Myeloma—A Multicenter Analysis
2026 · Maximilian Al‐Bazaz, Winfried Alsdorf, et al. · American Journal of Hematology · 2
Clinical Scores to Predict Toxicities and Outcomes in Patients with Multiple Myeloma Undergoing Bispecific T-cell Engager Therapy
2026 · Jan H. Frenking, Christine Riedhammer, et al. · Blood Cancer Discovery · 2
Prognostic importance of splicing-triggered aberrations of protein complex interfaces in cancer
2024 · Khalique Newaz, Christoph Schaefers, et al. · NAR Genomics and Bioinformatics · 2
Real-world analyses of bispecific antibodies and CAR-T cell therapy in relapsed or refractory multiple myeloma: a global TriNetX discovery and contemporary validation cohort
2026 · Theo Leitner, Lorenz Oelschläger, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1
Characteristics, treatment regimens, and outcomes of patients with true extramedullary multiple myeloma: a real-world monocentric analysis
2026 · Marie Harzer, Nils Gross-Fengels, et al. · Annals of Hematology · 1
PDF
How to approach the high-risk myeloma from induction through relapse?
2025 · Katja C. Weisel, Christoph Schaefers, et al. · Hematology · 1
Correction: Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement
2025 · Maximilian J. Steinhardt, Christoph Schaefers, et al. · Blood Cancer Journal · 1
PDF
Hepatitis E virus infections in people with multiple myeloma: an emerging challenge in the era of immunotherapeutic approaches
2025 · Maximilian Al-Bazaz, Sven Pischke, et al. · Haematologica · 1
PDF
Real-World Data on Outcome of Burkitt Lymphoma and Burkitt Leukemia Treated According to the GMALL B-ALL/NHL 2002 Protocol: A Tertiary Center Experience
2025 · Ricardo Kosch, Christoph Schaefers, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
PDF
T cell redirection as a new standard of care for relapsed multiple myeloma: impact on inpatient capacity, financial burden and infrastructural requirements in Germany
2025 · P. Ahmadi, W. Alsdorf, et al. · Bone Marrow Transplantation · 1
PDF
Activity of CAR-T Cells and Bispecific Antibodies in Multiple Myeloma with Extramedullary Involvement
2024 · Maximilian J. Steinhardt, Christoph Schaefers, et al. · Blood · 1
PDF
Multiple myeloma in the young: insights on prognosis, clinical features and treatment outcome derived from nationwide German registry data and a nested multicenter sample
2024 · Abdulaziz Kamili, Paymon Ahmadi, et al. · Haematologica · 1
Ceacam1 controls IL-2-dependent regulatory T cell induction in immune-mediated hepatitis
2018 · A. Horst, C. Wegscheid, et al. · Journal of Hepatology · 1
Belantamab mafodotin plus venetoclax in t(11;14)-positive relapsed or refractory multiple myeloma – the BELI(E)VE trial
2026 · Christoph Schaefers, Cyrus Khandanpour, et al. · BMC Cancer
Additional file 1 of Belantamab mafodotin plus venetoclax in t(11;14)-positive relapsed or refractory multiple myeloma – the BELI(E)VE trial
2026 · Christoph Schaefers, Cyrus Khandanpour, et al. · Figshare
Additional file 2 of Belantamab mafodotin plus venetoclax in t(11;14)-positive relapsed or refractory multiple myeloma – the BELI(E)VE trial
2026 · Christoph Schaefers, Cyrus Khandanpour, et al. · Figshare
Works count: 76
Citation count: 145
H-index: 6
I10-index: 5
Year
Topic
Type